Home › NCT04674969
Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature
RecruitingObservational study
Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature (ELEGANCE)
Who can join
Ages 18 and older · All sexes
Full eligibility criteria
Inclusion Criteria:
* Patients 18 years and older
* Written informed consent (patient data release-form)
* Use of any commercially available Boston Scientific drug-eluting device marketed for treatment of lesions in the peripheral vasculature and specified in the Registry Enrollment Guide
Exclusion Criteria:
* Life expectancy of \<1 year
About the study
The ELEGANCE Registry's objective is to collect Real-World Data (RWD), including populations previously not represented in Peripheral Vascular Disease (PVD) trials, health economics data, and to support the safe use of commercially available Boston Scientific Corporation (BSC) drug-eluting devices for the treatment of lesions located in the peripheral vasculature.
What is being tested
- Any eligible commercially available Boston Scientific Corporation (BSC) drug-eluting device. (device)
Sponsor: Boston Scientific Corporation · Participants: 5,000 · Started: Mar 29, 2021
Contact the study team
Official record on ClinicalTrials.gov — NCT04674969
Locations in the U.S.
| Arkansas | St. Bernard's Medical Center, Jonesboro |
| California | Cedars - Sinai Medical Center, Los Angeles
PIH Health Good Samaritan Hospital, Los Angeles
Adventist Health St Helena Hospital, St. Helena |
| Connecticut | Yale University School of Medicine, New Haven |
| Delaware | Christiana Hospital, Newport |
| District of Columbia | Washington Hospital Center, Washington D.C. |
| Florida | Tallahassee Memorial Hospital, Tallahassee |
| Georgia | Emory University Hospital, Atlanta
South Georgia Medical Center, Valdosta |
| Illinois | Rush University, Chicago
St. John's Hospital/ Prairie Education and Research Cooperative, Springfield |
| Indiana | Ascension St. Vincent's Hospital, Indianapolis |
| Louisiana | Ochsner Clinic Foundation, Kenner |
| Massachusetts | Beth Israel Deaconess Medical Center, Boston |
| Mississippi | North Mississippi Medical Center, Tupelo |
| New Jersey | Hackensack University Medical Center, Hackensack
Newark Beth Israel Medical Center, Newark |
| New York | Buffalo General Hospital, Buffalo
Columbia University, New York
Memorial Sloan Kettering Hospital, New York
Mount Sinai, New York
New York University Medical Center, New York
Weill Cornell Medicine/New York-Presbyterian Hospital, New York |
| North Carolina | Duke University Medical Center, Durham
Rex UNC Health (NC Heart and Vascular Research, LLC), Raleigh |
| Ohio | Cleveland Clinic Foundation, Cleveland
University Hospitals of Cleveland, Cleveland |
| Oklahoma | Ascension St. John Clinical Research Institute, Tulsa |
| Pennsylvania | Hospital University of Pennsylvania, Philadelphia
Thomas Jefferson University, Philadelphia |
| Rhode Island | The Miriam Hospital, Providence |
| Texas | Seton Medical Center, Austin
The University of Texas, Southwestern Medical Center, Dallas
Baylor College of Medicine, Houston
HeartPlace P.A., Plano |
| Virginia | Inova Fairfax Hospital, Fairfax |
| Washington | UW Medicine - Harborview Medical Center, Seattle |
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.